Skip secondary menu

Funding News - HIV-Associated CNS Disease

Archive folder iconHistorical Data

  • The information on this page is for historical and research purposes only.
  • For the most current NINDS funding announcements, please see the NINDS list of Active Funding Initiatives or Follow Us on Twitter for the latest funding news.

NINDS and NIMH request grant applications for research on viral and host genetic factors regulating HIV-associated central nervous system disease. This announcement is supported by 2 funding mechanisms: R01 and R21.

Despite the widespread use of anti-retroviral therapy, the prevalence of HIV-associated neurocognitive disorders (HAND) remains high. There remains much to learn about the evolving mechanisms of neuropathogenesis as people are living longer under therapy. This initiative will stimulate further research on the role of viral and host genetic factors in driving HAND pathophysiology in the setting of long-term treatment. It is a great opportunity for the neuroAIDS field to use state-of-the-art advanced genomic technologies and systems biology approaches to address questions relating to viral and host contribution to HIV neuropathogenesis.

Letters of Intent Due December 6, 2010

Applications Due January 6, 2011

Potential applicants should contact Dr. May Wong, program director, Neural Environment, NINDS, at 301-496-1431 or mw132k@nih.gov. For more information visit http://grants.nih.gov/grants/guide/rfa-files/RFA-MH-11-020.html or http://grants.nih.gov/grants/guide/rfa-files/RFA-MH-11-021.html.